The Four-Pillar Model of Hair Health: Biological Rationale, Clinical Evidence, and Priorities for Validation

Hair-follicle function depends on interactions among endocrine signaling, hair-shaft synthesis, inflammatory and redox regulation, cellular metabolism, vascular support, and regeneration. This narrative and integrative review organizes biological and clinical evidence into four interconnected domains: hormonal regulation, structural integrity, inflammatory–redox homeostasis, and metabolic–regenerative competence. The proposed Four-Pillar Model of Hair Health provides a conceptual framework for investigating these interactions and relating different levels of evidence to hair-specific outcomes. Within this framework, follicular resilience denotes the hypothesized capacity to maintain or recover follicular function under biological stress. It is a conceptual research construct without validated measurement indicators, diagnostic standards, or clinical thresholds. It cannot currently be used as a validated clinical endpoint or for routine patient assessment. Nutraceuticals illustrate the distinction between mechanistic activity and clinical benefit. Molecular effects across several domains do not establish therapeutic efficacy or superiority. Findings from cell culture, animal models, or other tissues cannot be directly extrapolated to human hair outcomes. Clinical benefits require hair-specific human trials of the formulation, dose, administration route, and population under consideration. Selected interventions have reported changes in hair density, count, shedding, or other outcomes, but heterogeneous formulations, baseline nutritional status, study methods, and potential publication bias limit generalization. As a narrative and integrative review, this work involved independent assessment of relevant titles, abstracts, and full texts by both authors, followed by joint discussion of eligibility and interpretation. The screening decisions were not recorded in a standardized study-level log, and original search exports were not retained. No formal risk-of-bias appraisal or quantitative meta-analysis was performed. The model complements established alopecia research and indication-specific treatment, including minoxidil and finasteride; it does not replace them. Prospective human studies must determine whether integrating the four domains adds information beyond established assessment and improves treatment selection or clinical outcomes.